Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 69 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Catheter Precision Inc | VTAK | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.5743 | 03:19:47 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.5743 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 1 | 69 | - | 0.34 - 0.748 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 03:19:47 | 69 | US$ 0.53 | USD |
Catheter Precision Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.98M | 7.03M | - | 442k | -70.57M | -10.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Catheter Precision News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/07/2024 | 15:38 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 5/07/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/06/2024 | 16:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 1/25/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/11/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/10/2024 | 15:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/08/2024 | 15:45 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 1/04/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/29/2023 | 07:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/22/2023 | 16:16 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 12/22/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/21/2023 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VTAK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.56 | 0.61 | 0.525 | 0.5629565 | 44,102 | 0.0143 | 2.55% |
| 1 Month | 0.4725 | 0.62 | 0.4171 | 0.5414614 | 44,619 | 0.1018 | 21.54% |
| 3 Months | 0.4068 | 0.62 | 0.40 | 0.5213625 | 36,431 | 0.1675 | 41.18% |
| 6 Months | 0.4406 | 0.748 | 0.3704 | 0.4909921 | 43,059 | 0.1337 | 30.34% |
| 1 Year | 0.60 | 0.748 | 0.34 | 0.4668467 | 47,927 | -0.0257 | -4.28% |
| 3 Years | 0.60 | 0.748 | 0.34 | 0.4668467 | 47,927 | -0.0257 | -4.28% |
| 5 Years | 0.60 | 0.748 | 0.34 | 0.4668467 | 47,927 | -0.0257 | -4.28% |
Catheter Precision Description
| Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. |
